Darzalex (daratumumab) - J&J
Rituxan (rituximab) - Roche
cyclophosphamide - Generic mfg.
A Rare Case of Immunotactoid Glomerulopathy Associated with Lymphoma and T-Cell Large Granular Lymphocytic Leukemia (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1254; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Patient received 2 cycles of rituximab, cyclophosphamide and dexamethasone but her creatinine increased to 3.21mg/dL and thereafter rituximab was switched to daratumumab. Patient had suboptimal renal response to B-cell directed therapy. However, she was able to achieve partial renal and hematological responses with plasma-cell targeted therapy." 
Clinical • Congestive Heart Failure • Glomerulonephritis • Heart Failure • Hematological Malignancies • Immunology • Leukemia • Leukopenia • Lupus Nephritis • Lymphoma • Lymphoplasmacytic Lymphoma • Multiple Myeloma • Nephrology • Non-Hodgkin's Lymphoma • Renal Disease • T Cell Non-Hodgkin Lymphoma • T-Cell Large Granular Lymphocyte Leukemia • Thrombocytopenia • Waldenstrom Macroglobulinemia
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4559952
 
Wing Han Christy Au; Ziad M. El-Zaatari; Nelson Leung; Oren Pasvolsky; Samih H. Nasr; Ala Abudayyeh
 
Oct 2, 2026
 
Prev Next